LEMAITRE VASCULAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
LEMAITRE VASCULAR, INC. (LMAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $10.37 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2018-03-09
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $10.37, a 156.68% increase from fiscal 2016.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $4.04, a 44.29% increase from fiscal 2015.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $2.80, a 0.36% decline from fiscal 2014.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2014 was $2.81, a 6.64% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2017-12-31 | $10.37 10-K · filed 2018-03-09 | |||
| 2017-09-30 | $4.04 10-Q · filed 2017-11-03 | |||
| 2016-12-31 | $4.04 10-K · filed 2018-03-09 | |||
| 2015-12-31 | $2.80 10-K · filed 2018-03-09 | |||
| 2015-09-30 | $4.04 10-Q · filed 2016-11-04 | $2.80 10-Q · filed 2015-11-06 | ||
| 2014-12-31 | $2.81 10-K · filed 2017-03-09 | |||
| 2014-09-30 | $2.80 10-Q · filed 2016-11-04 | $2.81 10-Q · filed 2014-11-06 | ||
| 2014-06-30 | $1.75 10-Q · filed 2015-08-06 | |||
| 2013-12-31 | $3.01 10-K · filed 2016-03-10 | |||
| 2013-09-30 | $3.00 10-Q · filed 2014-11-06 | |||
| 2012-12-31 | $2.91 10-K · filed 2015-03-18 | |||
| 2012-09-30 | $2.91 10-Q · filed 2013-11-07 | |||
| 2011-12-31 | $3.57 10-K · filed 2014-03-21 | |||
| 2011-09-30 | $3.57 10-Q · filed 2012-11-09 | |||
| 2011-06-30 | $3.42 10-Q · filed 2012-08-10 | |||
| 2010-12-31 | $3.43 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |